ARCHIVES

Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal

This article is from The Cancer Letter archive.

Vol. 37 No. 46 | December 16, 2011

Download PDF Visit The Full Archive

Related Articles

In Congress: NCI Defends Role of Advisor In Response To House Inquiry

September 19, 1997

ASCO Urges Increase In NIH, NCI Budgets.

January 25, 2008

In Brief: Henderson Names to HHA Post; Nurses Support Cigarette Tax Increase; FDA Staff Changes

May 7, 1993

Family History of BRCA Mutation Does Not Equal Increased Risk

October 28, 2011

Mammography Summit Planned For June In Milan.

March 1, 2002

“Significant changes should be made to reduce redundancy, streamline operations, promote collaboration, and optimize productivity.”

July 14, 1995